Dr. THAM Seng Kong
PhD. , MD (PRC)
Dr. THAM is an established member of the Malaysian Society for Stem Cell Research & Theraphy (MSCRT) and the Malaysia Association for Cell Therapy (MACT) in Malaysia. He is a veteran in the field of life sciences, with a genuine passion for the field of Cellular Therapy. Dr. THAM earned his Bachelor of Medicine from Xiamen University, Doctor of Medicine (MD) Integrated Chinese Medicine & Western Clinical Medicine (Oncology) from Guangzhou University of Chinese Medicine (GUCM) and Doctor of Medicine (MD) in Biomedical Engineering. Presently he has the privilege of treating and consulting international members of royalty, celebrities, and members of the elite. A well sought-after Educator on Best Practices, he also dedicates his time between clinical physicians and members of the public.
He is involved in ongoing extensive research on anti-aging cellular therapy since 2006. He works very closely with his Swiss and Asian counterparts in advancing the human understanding of cellular therapy and is eager to share his experiences in this field. A well sought-after Educator on Best Practices, he also dedicates his time between clinical physicians and members of the public.
He also actively participates in cancer research. One of his important scientific breakthroughs is the discovery of penetrating tyrosinase inhibitor to reduce the production of melanin for skin beauty and whitening. He also described in his recent publication on the successful construction of retroviral transfection system that could be developed as a means of gene therapy for hepatic carcinoma.
Dr. Tham as Group Chief Executive Officer and Group Chief Research Scientist will be the main personality leading and driving the ALPS Group to greater heights towards recognition as a global biotechnology company serving humanity.